회복된 B형간염 환자에서 Rituximab 치료 이후 발생한 전격성 간부전을 동반한 B형간염 바이러스의 재활성화 1예
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 정승민 | - |
dc.contributor.author | 손주현 | - |
dc.contributor.author | 김태엽 | - |
dc.contributor.author | 유기덕 | - |
dc.contributor.author | 안용우 | - |
dc.contributor.author | 배중호 | - |
dc.contributor.author | 전용철 | - |
dc.contributor.author | 최정혜 | - |
dc.date.accessioned | 2022-12-20T18:05:11Z | - |
dc.date.available | 2022-12-20T18:05:11Z | - |
dc.date.created | 2022-09-19 | - |
dc.date.issued | 2010-04 | - |
dc.identifier.issn | 1598-9992 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/175082 | - |
dc.description.abstract | It is well known that the reactivation of hepatitis B virus (HBV) may occur as an acute hepatitis after chemotherapy or immunosuppressive therapy. Although most of these cases have been reported in HBsAg-positive patients, there have been a few reports of HBV reactivation in HBsAg-negative patients. There have been concerns for the need to screen the reactivation as well as anti-viral prophylaxis in HBsAg-negative patients with possible HBV occult infection who are planning to undergo chemotherapy or immunosuppressive therapy. Rituximab, an anti-CD20 monoclonal antibody, is effective in the treatment of non-Hodgkin’s lymphoma. However, rituximab can affect the immunity against HBV, consequently increasing viral replication. In fact, there have been reports of HBV reactivation after treatment with rituximab. Here, we report a case of HBV reactivation following rituximab plus systemic chemotherapy in diffuse large B cell lymphoma patient who was HBsAg negative, anti-HBs positive, and anti-HBc positive, ultimately leading to treatment-unresponsive fulminant hepatic failure. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 대한소화기학회 | - |
dc.title | 회복된 B형간염 환자에서 Rituximab 치료 이후 발생한 전격성 간부전을 동반한 B형간염 바이러스의 재활성화 1예 | - |
dc.title.alternative | Fulminant Hepatic Failure with Hepatitis B Virus Reactivation after Rituximab Treatment in a Patient with Resolved Hepatitis B | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 손주현 | - |
dc.contributor.affiliatedAuthor | 전용철 | - |
dc.contributor.affiliatedAuthor | 최정혜 | - |
dc.identifier.doi | 10.4166/kjg.2010.55.4.266 | - |
dc.identifier.scopusid | 2-s2.0-77955494701 | - |
dc.identifier.bibliographicCitation | 대한소화기학회지, v.55, no.4, pp.266 - 269 | - |
dc.relation.isPartOf | 대한소화기학회지 | - |
dc.citation.title | 대한소화기학회지 | - |
dc.citation.volume | 55 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 266 | - |
dc.citation.endPage | 269 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001439591 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | antineoplastic agent | - |
dc.subject.keywordPlus | antivirus agent | - |
dc.subject.keywordPlus | drug derivative | - |
dc.subject.keywordPlus | entecavir | - |
dc.subject.keywordPlus | guanine | - |
dc.subject.keywordPlus | monoclonal antibody | - |
dc.subject.keywordPlus | rituximab | - |
dc.subject.keywordPlus | virus DNA | - |
dc.subject.keywordPlus | aged | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | case report | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | hepatitis B | - |
dc.subject.keywordPlus | Hepatitis B virus | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | isolation and purification | - |
dc.subject.keywordPlus | large cell lymphoma | - |
dc.subject.keywordPlus | liver failure | - |
dc.subject.keywordPlus | recurrent disease | - |
dc.subject.keywordAuthor | Hepatitis B | - |
dc.subject.keywordAuthor | Reactivation | - |
dc.subject.keywordAuthor | HBsAg | - |
dc.subject.keywordAuthor | Rituximab | - |
dc.subject.keywordAuthor | Lymphoma | - |
dc.identifier.url | http://click.ndsl.kr/servlet/OpenAPIDetailView?keyValue=01866548&target=NART&cn=NART53025602 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.